cash flow reconciliationreview2026-06-30
Operating, investing and financing flows differ from the reported change in cash by 49000000, beyond tolerance 13340000.00.
Revenue
$6.50B
Fiscal year ended 2026-06-30Operating income
$984.00M
Fiscal year ended 2026-06-30Free cash flow
$763.00M
Fiscal year ended 2026-06-303M CO (MMM) reported revenue of $6.50B and net income of $933.00M for the fiscal year ended 2026-06-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from 3M CO’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.
Income
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.50B | $6.03B | $6.13B | $6.52B | $6.34B | $5.95B | $6.01B | $6.29B | $6.26B | $6.02B |
| Cost of revenue | $3.82B | $3.57B | $4.08B | $3.79B | $3.65B | $3.48B | $3.74B | $3.65B | $3.57B | $3.48B |
| Gross profit | $2.68B | $2.46B | $2.06B | $2.72B | $2.70B | $2.48B | $2.27B | $2.65B | $2.68B | $2.53B |
| Operating income | $984.00M | $1.40B | $796.00M | $1.45B | $1.14B | $1.25B | $1.08B | $1.32B | $1.27B | $1.15B |
| Net income | $933.00M | $653.00M | $577.00M | $834.00M | $723.00M | $1.12B | $728.00M | $1.37B | $1.14B | $928.00M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 522.40M | shares 532.80M | Unavailable | shares 538.10M | shares 540.60M | shares 547.70M | Unavailable | shares 552.70M | shares 554.80M | shares 555.90M |
| Pretax income | $1.12B | $878.00M | $758.00M | $1.15B | $923.00M | $1.38B | $759.00M | $1.72B | $1.41B | $929.00M |
| Income tax expense | $183.00M | $221.00M | $185.00M | $308.00M | $245.00M | $265.00M | $33.00M | $348.00M | $203.00M | $220.00M |
| Diluted EPS | $1.78 | $1.23 | Unavailable | $1.55 | $1.34 | $2.04 | $1.33 | $2.48 | $2.07 | $1.67 |
| Selling, general & administrative | $1.06B | $744.00M | $965.00M | $820.00M | $1.27B | $945.00M | $899.00M | $1.06B | $1.13B | $1.13B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Total assets | $34.92B | $35.44B | $37.73B | $37.61B | $37.99B | $39.95B | $39.87B | $40.88B | $43.38B | $55.24B |
| Current assets | $14.11B | $14.39B | $16.39B | $16.09B | $13.43B | $15.66B | $15.88B | $16.30B | $19.52B | $21.61B |
| Total liabilities | $31.92B | $32.12B | $32.99B | $32.94B | $33.64B | $35.43B | $35.97B | $36.18B | $39.39B | $50.31B |
| Current liabilities | $11.38B | $9.03B | $9.60B | $8.73B | $7.81B | $9.45B | $11.26B | $11.39B | $14.34B | $13.16B |
| Total equity incl. NCI | $3.00B | $3.31B | $4.75B | $4.68B | $4.35B | $4.52B | $3.89B | $4.69B | $3.99B | $4.93B |
| Temporary (mezzanine) equity | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Inventory | $3.77B | $3.69B | $3.66B | $3.89B | $4.08B | $3.87B | $3.70B | $4.04B | $4.06B | $4.90B |
| Accounts receivable | $3.93B | $3.75B | $3.53B | $3.78B | $3.76B | $3.50B | $3.19B | $3.53B | $3.58B | $4.75B |
| Goodwill | $6.37B | $6.38B | $6.42B | $6.42B | $6.43B | $6.34B | $6.28B | $6.40B | $6.32B | $12.81B |
| Long-term debt | $10.90B | $10.91B | $10.93B | $11.85B | $12.48B | $12.31B | $11.12B | $11.32B | $11.78B | $20.59B |
| Accounts payable | $3.11B | $2.79B | $2.70B | $2.74B | $2.84B | $2.76B | $2.66B | $2.69B | $2.81B | $3.37B |
Cash flow
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $986.00M | $574.00M | $1.58B | $1.76B | -$954.00M | -$79.00M | $1.82B | -$1.79B | $1.02B | $767.00M |
| Capital expenditures | $223.00M | $225.00M | $248.00M | $218.00M | $208.00M | $236.00M | $291.00M | $246.00M | $269.00M | $375.00M |
| Investing cash flow | -$483.00M | $60.00M | -$405.00M | $465.00M | $70.00M | $1.22B | -$1.15B | -$1.20B | -$463.00M | -$393.00M |
| Financing cash flow | -$1.33B | -$2.12B | -$617.00M | -$1.21B | -$1.77B | -$422.00M | -$1.08B | -$1.08B | -$1.36B | $4.62B |
| Net change in cash | -$774.00M | -$1.51B | $564.00M | $959.00M | -$2.61B | $726.00M | -$450.00M | -$4.03B | -$828.00M | $4.98B |
| Stock-based compensation | $41.00M | $80.00M | $43.00M | $53.00M | $44.00M | $85.00M | $47.00M | $42.00M | $171.00M | $29.00M |
| Common dividends paid | $401.00M | $412.00M | $387.00M | $389.00M | $390.00M | $396.00M | $378.00M | $383.00M | $386.00M | $835.00M |
| Common share repurchases | $994.00M | $2.00B | $552.00M | $472.00M | $953.00M | $1.27B | $705.00M | $675.00M | $400.00M | $21.00M |
| Depreciation & amortization | $335.00M | $326.00M | $430.00M | $298.00M | $290.00M | $290.00M | $322.00M | $310.00M | $301.00M | $430.00M |
Derived
| Metric | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $763.00M | $349.00M | $1.34B | $1.54B | -$1.16B | -$315.00M | $1.53B | -$2.03B | $752.00M | $392.00M |
| Gross margin | 41.3% | 40.7% | 33.6% | 41.8% | 42.5% | 41.6% | 37.7% | 42.1% | 42.9% | 42.1% |
| Operating margin | 15.1% | 23.2% | 13.0% | 22.2% | 18.0% | 20.9% | Unavailable | 20.9% | 20.3% | 19.1% |
| FCF margin | 11.7% | 5.8% | 21.8% | 23.6% | -18.3% | -5.3% | 25.4% | -32.3% | 12.0% | 6.5% |
| SBC / revenue | 0.6% | 1.3% | 0.7% | 0.8% | 0.7% | 1.4% | Unavailable | 0.7% | 2.7% | 0.5% |
| Current ratio | 1.24x | 1.59x | 1.71x | 1.84x | 1.72x | 1.66x | 1.41x | 1.43x | 1.36x | 1.64x |
| Revenue YoY growth | 2.5% | 1.3% | 2.0% | 3.5% | 1.4% | -1.0% | 0.1% | 0.4% | -0.4% | -0.6% |
| Net margin | 14.4% | 10.8% | 9.4% | 12.8% | 11.4% | 18.7% | 12.1% | 21.8% | 18.3% | 15.4% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 3.4% | 3.7% | 4.0% | 3.3% | 3.3% | 4.0% | Unavailable | 3.9% | 4.3% | 6.2% |
| Long-term debt / equity | 3.63x | Unavailable | 2.30x | 2.54x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 16.3% | 25.2% | 24.4% | 26.9% | 26.5% | 19.1% | 4.3% | 20.2% | 14.4% | 23.7% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MMM in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-07-21View SEC filing
10-Q · Filed 2026-04-21View SEC filing
10-K · Filed 2026-02-03View SEC filing
10-Q · Filed 2025-10-21View SEC filing
10-Q · Filed 2025-07-18View SEC filing
10-Q · Filed 2025-04-22View SEC filing
Reconciliation checks needing review
2 periods on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.
cash flow reconciliationreview2025-09-30
Operating, investing and financing flows differ from the reported change in cash by 44000000, beyond tolerance 17560000.00.